- Home
- NTRB vs FORA Comparison
NTRB vs FORA Comparison
Compare NTRB & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTRB | FORA |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.7M | 69.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTRB | FORA |
|---|---|---|
| Price | $4.62 | $2.20 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 21.2K | ★ 39.9K |
| Earning Date | 12-03-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,578,059.00 | ★ $28,106,911.00 |
| Revenue This Year | $560.75 | $47.82 |
| Revenue Next Year | $588.39 | $10.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.92 | 37.47 |
| 52 Week Low | $3.72 | $1.64 |
| 52 Week High | $11.78 | $4.03 |
Technical Indicators
Market Signals| Indicator | NTRB | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 50.12 |
| Support Level | $4.59 | $2.03 |
| Resistance Level | $4.99 | $2.21 |
| Average True Range (ATR) | 0.30 | 0.10 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.83 | 55.58 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.